Увеит, ассоциированный с ювенильным идиопатическим артритом у детей Республики Саха (Якутия): эпидемиологические данные и серия клинических наблюдений

В статье представлено сплошное когортное ретроспективное исследование пациентов с диагнозом ювенильный идиопатический артрит (ЮИА), проходивших обследование и лечение в Педиатрическом центре Республиканской больницы №1–Национального центра медицины им. М.Е. Николаева в 2016-2023 гг. Для детального анализа отобраны пациенты, развившие увеит. Распространенность увеита в РС(Я) составила на 100 000 детского населения 8,6, из них детей саха 11,8, русских – 5,6. Увеит среди детей с ЮИА чаще встречается у мальчиков национальности саха и чаще у детей более старшего возраста без взаимосвязи с типами ЮИА. Продемонстирована низкая эффективность стартовой терапии метотрексатом. Все случаи увеита de-novo зафиксированы только у детей национальности саха, большая часть из которых мальчики.

1. Аклаева Н.А., Аветисов С.Э., Егоров Е.А. Национальное руководство по офтальмологии. 2-е и.зд. ГЭОТАР-Медиа, 2022. 904 с.

2. Клинические рекомендации. Увеиты, ассоциированные с ювенильным идиопатическим артритом / Общероссийск. обществен. орг. «Ассоциация врачей-офтальмологов». МЗ РФ, 2017.

3. Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis/ Ramanan AV, Dick AD, Jones AP [et al.] // N Engl J Med. 2017 Apr 27;376(17):1637–46.

4. Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis. Arthritis Care Res./ Angeles-Han ST, Ringold S, Beukelman T, [et al.] // American College of Rheumatology/2019 2019 Jun;71(6):703–16.

5. Bauermann P, Heiligenhaus A, Heinz C. Effect of Janus Kinase Inhibitor Treatment on Anterior Uveitis and Associated Macular Edema in an Adult Patient with Juvenile Idiopathic Arthritis. Ocul Immunol Inflamm. 2019 Nov 17;27(8):1232– 4.

6. Chronic Uveitis in Children/Kumar P, Gupta A, Bansal R, [et al.] // Indian J Pediatr. 2022 Apr;89(4):358–63.

7. Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ)/Yasumura J, Yashiro M, Okamoto N, [et al.] //Pediatr Rheumatol. 2019 Dec;17(1):15.

8. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus/Bou R, Adán A, Borrás F [et al.] //Rheumatol Int. 2015;35(5):777.

9. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative/ Constantin T, Foeldvari I, Anton J, [et al.]. //Ann Rheum Dis. 2018 Aug; 77(8):1107–17.

10. Current evidence of anti-tumor necrosis factor α treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs/ Simonini G, Druce K, Cimaz R, [et al.] //Arthritis Care Res. 2014 Jul; 66(7):1073–84.

11. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach/Simonini G, Paudyal P, Jones GT, [et al.] //Rheumatol Oxf Engl. 2013 May;52(5):825–31.

12. Etanercept and uveitis in patients with juvenile idiopathic arthritis/Heinrike Schmeling, Schmeling H, Gerd Horneff, [et al.] //Rheumatology. 2005 Aug 1;44(8):1008–11.

13. Evaluation of Patients with Juvenile Idiopathic Arthritis- Associated Uveitis from Rheumatology Perspective/ Bağlan E, Özdel S, Özdemi̇R K , [et al.]// Turk J Pediatr Dis. 2022 Feb 28;1–4.

14. Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis/Heiligenhaus A, Michels H, Schumacher C, [et al.]. // Rheumatol Int. 2012 May;32(5):1121–33.

15. Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER/ Sahin S, Acari C, Sonmez HE, [et al.].// Pediatr Rheumatol Online J. 2021 Aug 23;19(1):134.

16. Here Comes the SUN (Part 2): Standardization of Uveitis Nomenclature for Disease Classification Criteria/Van Gelder RN, Sen HN, Tufail A, [et al.] //Am J Ophthalmol. 2021 Aug;228:A2–6.

17. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature/ Carvounis PE, Herman DC, Cha S, [et al.] // Albrecht Von Graefes Arch Für Klin Exp Ophthalmol. 2006 Mar;244(3):281–90.

18. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis/Pirjo Tynjälä, Tynjälä P, Päivi Lindahl, [et al.] //Ann Rheum Dis. 2006 Oct 26;66(4):548–50.

19. Juvenile idiopathische Arthritis/Klotsche J, K. Minden, Minden K, [et al.]. 2007 Jan 1;175– 262.

20. Lim LL, Fraunfelder FW, Rosenbaum JT. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum. 2007 Oct;56(10):3248–52.

21. Long-term outcomes of cataract surgery in children with uveitis/Yangzes S, Seth N, Singh R, [et al.] //Indian J Ophthalmol. 2019;67(4):490.

22. Occurrence of uveitis and flares in juvenile idiopathic arthritis patients upon tumour necrosis factor (tnf)- inhibitors. /Baucks C, Zimmer A, Hospach T, [et al.] In: Scientific Abstracts [Internet]. BMJ Publishing Group Ltd and European League Against Rheumatism; 2024 [cited 2024 Sep 13]. p. 1164.2-1165. Available from: https://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2024-eular.2027

23. Outcome of uveitis in juvenile idiopathic arthritis and spondyloarthritis patients – a 5-year follow up study/ Pinheiro FO, Leuzinger-Dias M, Fernandes BM, [et al.]// In: XXXIX Congresso Brasileiro de Reumatologia [Internet]. Sociedade Brasileiro de Reumatologia; 2022 [cited 2024 Sep 13]. Available from: http://www.reumatologia.org.br/downloads/anais2022/%28D%291754.pdf

24. Pediatric uveitis: A comprehensive review/ Maleki A, Anesi SD, Look-Why S, , [et al.] //Surv Ophthalmol. 2022 Mar;67(2):510–29.

25. Presence of uveitis as indicator of juvenile idiopathic arthritis severity: results of a retrospective cohort study/Yakovlev A.A., Gaidar E.V., Belozerov K.E., [et al.] //Pediatr. 2023 Jul 6;14(2):37–47.

26. Prevalence and structure of juvenile idiopathic arthritis in children in the Republic of Sakha (Yakutia)/Vinokurova F.V., Argunova V.M., Sleptsova P.A., [et al.] //Yakut Med J. 2020;(4):6– 9.

27. Quartier P. Juvenile Idiopathic Arthritis-Associated Chronic Uveitis: Recent Therapeutic Approaches. J Clin Med. 2021 Jun 30;10(13):2934. 28. Ravelli A, Martini A. Juvenile idiopathic arthritis. 2007;369.

28. Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids/ Thorne JE, Woreta FA, Dunn J, [et al.]. //Ophthalmology. 2010 Jul;117(7):1436–41.

29. Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFα agents/ Rotraud K. Saurenmann, Saurenmann RK, Alex V. Levin, [et al.] // J Pediatr. 2006 Dec 1;149(6):833–6.

30. Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Clin Immunol. 2020 Feb;211:108322.

31. Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140(3):509–16.

32. The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database/Minden K, Niewerth M, Listing J, [et al.] //Clin Exp Rheumatol. 2009 Sep 1;27(5):863–9.

33. The Large Hellenic Study of Uveitis: Diagnostic and Therapeutic Algorithms, Complications, and Final Outcome/ Kalogeropoulos D, Asproudis I, Stefaniotou M, [et al.] l.// Asia-Pac J Ophthalmol. 2023 Jan;12(1):44–57.

34. Update on biologic therapies for juvenile idiopathic arthritis-associated uveitis/Thomas J, Kuthyar S, Shantha JG, [et al.] //Ann Eye Sci. 2021 Jun;6:19. 36. Update on the management of uveitis in children: an overview for the clinician/Kim L, Li A, Angeles-Han S, [et al.] //Expert Rev Ophthalmol. 2019 Sep 3;14(4–5):211–8.

35. Uveitis Associated with Juvenile Idiopathic Arthritis./Charlotte L. L. I. van Meerwijk, Jonas J.W. Kuiper, Joeri W van Straalen, , [et al.]. 2023 Nov 15;1–9.

36. Uveitis in oligoarticular juvenile idiopathic arthritis patients and in juvenile spondyloarthritis/ enthesitisrelated arthritis – is there any difference? / Martins A., Ganhão S., Oliveira Pinheiro F., [et al.] //Ann Rheum Dis. 2023 Jun 1;82(Suppl 1):672.